APx Acquisition Corp. I (APXIF)
| Market Cap | 54.61M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -119.06K |
| Shares Out | 4.83M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 49,600 |
| Average Volume | 3,958 |
| Open | 11.40 |
| Previous Close | 11.60 |
| Day's Range | 11.39 - 11.60 |
| 52-Week Range | 5.00 - 12.89 |
| Beta | 0.02 |
| RSI | 45.30 |
| Earnings Date | May 23, 2025 |
About APx Acquisition I
APx Acquisition Corp. I does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Nashville, Tennessee. [Read more]
Financial Performance
Financial StatementsNews
APX Acquisition Corp. I Announces Nasdaq Delisting Notification for Warrants and Units
NASHVILLE, Tenn. , Nov. 1, 2024 /PRNewswire/ -- As previously announced, on September 4, 2024, APX Acquisition Corp. I (NASDAQ: APXI) (the "Company"), received a written notice from the Listing Qual...
APX Acquisition Corp. I Reports 10-K Delinquency Notice
NASHVILLE, Tenn. , June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficien...
APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform
NASHVILLE, Tenn. , March 26, 2024 /PRNewswire/ -- APx Acquisition Corp. I (NASDAQ: APXI) ("APx"), a publicly traded special purpose acquisition company, OmnigenicsAI Corp ("OmnigenicsAI"), a precision...
APX Acquisition Corp. I receives Nasdaq notice on late filing of its Form 10-Q
NASHVILLE, Tenn., Dec. 28, 2023 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficiency...
APX Acquisition Corp. I & Bioceres Group Announce Letter of Intent for a Business Combination with a Precision Medicine Diagnostic and Wellness Services Company
NASHVILLE, Tenn. , Dec. 1, 2023 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("Company"), a publicly traded special purpose acquisition company, announced today that it has signed a non-bind...
APx Acquisition Corp. I Receives NASDAQ Notification of Non-Compliance With Listing Rules
MEXICO CITY--(BUSINESS WIRE)--APx Acquisition Corp. I (NASDAQ: APXI) (“APx” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, sh...